"Exposing one lie is the same as exposing 1,000 lies," Ramey told CNBC via email. "He (Ackman) can't discern the difference anymore between truth and his fictional view of events."
Ramey provided CNBC with a series of emails he claims prove that he voluntarily left his job at Davidson. In one correspondence, dated January 21, 2014, Ramey emailed John Rogers, a Senior Vice President in charge of Institutional Research, alerting him of his plans to leave the firm in early February. In a return email, sent the following day back to Ramey and also obtained by CNBC, Rogers responds, "I am sorry to see you leave Davidson, but understand the opportunity you have."
Read More Teary Ackman on HLF: 'Time to shut the company down'
Ramey also provided an email he sent directly to Ackman on Tuesday, following the hedge fund manager's presentation, demanding a retraction—urging Ackman to "correct it or deal with it."
When reached for comment by phone, Ackman responded to CNBC by email, saying "I received an email from Tim Ramey complaining about a statement I made in the presentation that suggested that he may have been fired by D. A. Davidson. Tim has told me that he was not fired. Please make sure to correct the record."
On Tuesday afternoon D.A. Davidson & Co. confirmed the conditions of Ramey's departure from the firm.
"There is no truth to the suggestion that Tim Ramey was fired from D.A. Davidson & Co. He left on his own accord. We wish him well," the company said, in a statement.
Clearly you know nothing about Allergan. They've been best in class for years. Highest multiple in their class of companies for years. Never missing numbers for years. Innovation combined with making products as durable as possible has been fundamental. Opposite of valeant
Along your same hypocrite logic, the amount of money one in his position could stand to make if this deal goes down (it's in public filings) should illuminate the sincerity in concern over the business model and stock component.
deal won't get done. they are scrambling to cover up their debt.
so the light just turned on for Pyott ? how do you explain how much stock he dumped earlier this year ? ( well more than half of his holdings )
Certainly Allergan is on a mission to unleash shareholder value. That should be viewed as a good thing to AGN shareholders. However, given your investment decisions to not be an Allergan shareholder and rather a Valeant shareholder, one can empathize with your desperation. But we don't want Valeant paper because then we will find ourselves in the same situation as you.
That 's pretty funny but I knew right away that it wasn't our little troll because he did not misspell or have a typo every third word.